Taro-Tramadol ER, Tablets
« Back to list view

Product Information

  • DIN:
    02450429
  • Active Ingredients :
    tramadol hydrochloride
  • Innovator Name:
    Tridural®
  • Category:
    Opioid Analgesic
  • Dosage form:
    Tablet, Extended-Release
  • Strength:
    100 mg
  • Route of Administration:
    Oral
  • Colour:
    White
  • Shape:
    round shape, biconvex, bevelled edge with release portal on the center of the tablet on any one side
  • Markings:
    ‘531’ with black ink on one side and plain on the other side
  • Package size:
    100 bottle
  • UPC Code:
    063691075764
  • Description :
    White, round shape, biconvex, bevelled edge, coated tablet with release portal on the center of the tablet on any one side, imprinted ‘531’ with black ink on one side and plain on the other side.
  • Non-medicinal ingredients :
    cellulose acetate, hydroxypropyl methylcellulose, magnesium stearate, mannitol, nonvolatile components of Opadry Black (ammonium hydroxide, iron oxide black, and shellac glaze), polyethylene glycol, and pregelatinised starch.
Taro-Tramadol ER, Tablets

All brand names and trademarks referenced remain the property of their respective owners.

To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.

For Provincial Formulary Status click here

Product Information

  • DIN:
    02450437
  • Active Ingredients :
    tramadol hydrochloride
  • Innovator Name:
    Tridural®
  • Category:
    Opioid Analgesic
  • Dosage form:
    Tablet, Extended-Release
  • Strength:
    200 mg
  • Route of Administration:
    Oral
  • Colour:
    White
  • Shape:
    round shape, biconvex, bevelled edge with release portal on the center of the tablet on any one side
  • Markings:
    imprinted ‘533’ with black ink on one side and plain on the other side
  • Package size:
    100 bottle
  • UPC Code:
    063691075788
  • Description :
    White, round shape, biconvex, bevelled edge, coated tablet with release portal on the center of the tablet on any one side, imprinted ‘533’ with black ink on one side and plain on the other side.
  • Non-medicinal ingredients :
    cellulose acetate, hydroxypropyl methylcellulose, magnesium stearate, mannitol, nonvolatile components of Opadry Black (ammonium hydroxide, iron oxide black, and shellac glaze), polyethylene glycol, and pregelatinised starch.
Taro-Tramadol ER, Tablets

All brand names and trademarks referenced remain the property of their respective owners.

To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.

For Provincial Formulary Status click here

Product Information

  • DIN:
    02450445
  • Active Ingredients :
    tramadol hydrochloride
  • Innovator Name:
    Tridural®
  • Category:
    Opioid Analgesic
  • Dosage form:
    Tablet, Extended-Release
  • Strength:
    300 mg
  • Route of Administration:
    Oral
  • Colour:
    White
  • Shape:
    round shape, biconvex, bevelled edge with release portal on the center of the tablet on any one side
  • Markings:
    imprinted ‘537’ with black ink on one side and plain on the other side
  • Package size:
    100 bottle
  • UPC Code:
    063691075771
  • Description :
    White, round shape, biconvex, bevelled edge, coated tablet with release portal on the center of the tablet on any one side, imprinted ‘537’ with black ink on one side and plain on the other side.
  • Non-medicinal ingredients :
    cellulose acetate, hydroxypropyl methylcellulose, magnesium stearate, mannitol, nonvolatile components of Opadry Black (ammonium hydroxide, iron oxide black, and shellac glaze), polyethylene glycol, and pregelatinised starch
Taro-Tramadol ER, Tablets

All brand names and trademarks referenced remain the property of their respective owners.

To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.

For Provincial Formulary Status click here